OneSource Specialty Pharma Limited (NSE:ONESOURCE)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Contract Development & Manufacturing Organization	13.00B	1.72B	387.14M
Contract Development & Manufacturing Organization Growth	655.93%	344.07%	-
Total	13.00B	1.72B	387.14M
Total Growth	655.93%	344.07%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
India	1.94B	1.18B	266.11M
India Growth	64.09%	344.61%	-
Ireland	1.75B	-	-
United States of America	5.06B	-	-
Rest of The World	5.69B	536.03M	-
Rest of The World Growth	962.33%	-	-
outside India	-	-	121.03M
Total	14.45B	1.72B	387.14M
Total Growth	740.43%	344.07%	-

Source: S&P Global Market Intelligence.